RE:RE:great 3rd q resultsResults look pretty good, but note that a chunk of the profit comes from the foreign exchange gain due to the change in value of the $Cdn vs the $US. EPS is 4 cents a share without that. Margins were down due to resin price increases, but they should be able to mitigate that with pricing increases on their products. Agree completely on Advaseal. If they don't get approval for that, I will probably exit the stock. Unfortunate that the analysis to prove equivalence with existing active ingredients is taking longer than expected, but good that there is no indication that there is any problem.